Does Blue Cross of Idaho Cover Cialis?

Blue Cross of Idaho Formulary Basics for Cialis and Tadalafil

Blue Cross of Idaho publishes separate drug formularies for its commercial, marketplace (exchange), and Medicare Advantage product lines. Brand-name Cialis (tadalafil, manufactured by Eli Lilly) lost patent exclusivity in September 2018, and generic tadalafil tablets entered the U.S. market at a fraction of the brand cost [1]. Since that shift, nearly all Blue Cross of Idaho commercial and exchange plans have removed brand Cialis from their preferred formularies, replacing it with one or more generic tadalafil products.

Generic tadalafil usually appears on Tier 2 (preferred generic or preferred brand) or Tier 3 (non-preferred brand) of the plan's drug list. The tier placement matters because it directly controls your copay or coinsurance. Tier 2 copays on a typical Blue Cross of Idaho PPO or EPO plan range from $20 to $45, while Tier 3 copays can reach $50 to $75 per fill [2]. If your plan still lists brand Cialis at all, it will almost certainly sit on a specialty or non-preferred tier with significantly higher cost-sharing.

You can verify your specific plan's formulary by logging into the Blue Cross of Idaho member portal or by calling the number on the back of your insurance card. Formularies are updated quarterly, so a drug's tier can change at any renewal cycle. The American Urological Association (AUA) recognizes all PDE5 inhibitors, including tadalafil, sildenafil, vardenafil, and avanafil, as first-line oral therapy for erectile dysfunction (ED), which supports medical-necessity arguments during the appeals process [3].

Prior Authorization and Step-Therapy Requirements

Many Blue Cross of Idaho plans require a prior authorization (PA) before covering tadalafil, especially for the daily 2.5 mg or 5 mg dose used to treat both erectile dysfunction and benign prostatic hyperplasia (BPH). The PA process typically asks the prescribing physician to document at least one of the following: a confirmed diagnosis of ED or BPH, an adequate trial (usually 4 to 6 doses) of generic sildenafil that was ineffective or caused intolerable side effects, or a medical contraindication to sildenafil such as concurrent use of a moderate CYP3A4 inhibitor where sildenafil dose adjustments become impractical [4].

Step therapy is the most common barrier. Blue Cross of Idaho, like many commercial payers nationwide, designates generic sildenafil as the first-step PDE5 inhibitor because its wholesale acquisition cost sits approximately 80% below generic tadalafil on a per-dose basis [5]. A 2019 analysis of commercial claims data from IQVIA found that 72% of U.S. commercial plans imposed step therapy on at least one PDE5 inhibitor, with sildenafil as the required first step in 89% of those plans [6].

If your prescriber submits a PA and it is denied, you have the right to appeal. Blue Cross of Idaho must respond to a standard appeal within 30 calendar days for non-urgent requests or 72 hours for urgent requests, per Idaho Department of Insurance regulations [7]. The AUA Guidelines Panel states: "Clinicians should offer oral PDE5 inhibitors as first-line therapy for ED, selecting the agent based on patient preference, cost, and side-effect profile" [3]. This language supports the argument that tadalafil's unique 36-hour duration of action or its daily-dosing option for concurrent BPH represents a clinically meaningful difference from sildenafil, not merely a convenience preference.

How Medicare Advantage Plans Handle Erectile Dysfunction Drugs

If your Blue Cross of Idaho coverage is a Medicare Advantage plan, the rules change substantially. Under federal statute, Medicare Part D explicitly excludes coverage for drugs "used for the treatment of sexual or erectile dysfunction" [8]. This exclusion applies to all PDE5 inhibitors when prescribed specifically for ED: tadalafil, sildenafil, vardenafil, and avanafil.

There is one notable exception. Daily tadalafil 5 mg carries an FDA-approved indication for BPH (signs and symptoms of benign prostatic hyperplasia), independent of its ED indication [9]. When a physician prescribes tadalafil 5 mg daily and documents BPH as the primary diagnosis (ICD-10 code N40.1 rather than N52.9), some Medicare Advantage Part D plans will cover it under the BPH indication. A 2021 survey published in the Journal of Urology found that 38% of Medicare Part D plans covered daily tadalafil for BPH after prior authorization, up from just 12% in 2017 [10].

The distinction is diagnosis-driven. Your physician's office must ensure the prescription and any PA paperwork reference BPH, not ED, as the treatment indication. If the claim is submitted with an ED diagnosis code, it will be automatically denied under the Part D exclusion regardless of the drug's BPH utility.

Out-of-Pocket Costs: Brand Cialis vs. Generic Tadalafil

The cost gap between brand Cialis and generic tadalafil is wide. Brand Cialis carries an average retail price of approximately $490 for thirty 20 mg tablets without insurance, according to GoodRx price-tracking data as of early 2026 [11]. Generic tadalafil 20 mg, by contrast, averages $25 to $80 for the same quantity at major Idaho retail pharmacies when paying cash, and $10 to $45 with Blue Cross of Idaho commercial plan coverage applied.

For the daily 5 mg dose, a 30-day supply of generic tadalafil costs approximately $30 to $90 cash price. With a Tier 2 commercial formulary placement, your copay could fall to $15 to $40. A Tier 3 placement pushes that range to $40 to $75.

If you are on a high-deductible health plan (HDHP) paired with a health savings account (HSA), you will pay the full negotiated rate until your deductible is met. Blue Cross of Idaho's most popular HDHP products carry individual deductibles of $1,600 to $3,200, meaning many members pay out-of-pocket for tadalafil early in the plan year [12]. Using a manufacturer copay card is not an option for generic tadalafil because those programs are typically restricted to branded products. However, GoodRx, RxSaver, and similar discount-card programs often beat the insured copay for members who have not met their deductible.

A cost-effectiveness analysis published in the Journal of Sexual Medicine compared PDE5 inhibitors on a per-successful-intercourse basis and found that generic tadalafil 5 mg daily cost $3.10 to $5.40 per successful attempt versus $4.80 to $7.20 for on-demand sildenafil 100 mg, depending on frequency of use [13]. Daily dosing eliminates the need to plan around a dosing window, which can improve adherence. A 2020 retrospective cohort study in BJU International reported that men on daily tadalafil had a 12-month medication possession ratio (MPR) of 0.74 compared with 0.51 for on-demand PDE5 inhibitor users [14].

What to Do If Your Claim Is Denied

A denial is not the end of the process. Blue Cross of Idaho follows a multi-level appeals structure required by Idaho Code §41-5903 and the federal Affordable Care Act's external review provisions [7]. Here is a practical sequence for overturning a tadalafil denial.

First, ask your physician's office to submit a peer-to-peer review with the Blue Cross of Idaho pharmacy benefit manager. During this call, the prescriber can explain why sildenafil failed or is contraindicated. Common successful arguments include: sildenafil-associated headache or visual disturbances (reported in 16% and 6% of users, respectively, in pooled trial data) [15], the patient's need for daily PDE5 inhibitor therapy for concurrent BPH, or a drug interaction that makes sildenafil's CYP3A4 metabolism profile riskier than tadalafil's in that patient's medication regimen.

Second, if the peer-to-peer does not succeed, file a formal internal appeal in writing. Include a letter of medical necessity from the prescriber, relevant office notes, and a copy of the AUA guideline recommendation. The AUA's 2018 ED guideline states: "Patients should be informed about the availability of different PDE5 inhibitors and the differences in their pharmacokinetic profiles, including the prolonged half-life of tadalafil" [3]. This supports the clinical rationale for tadalafil selection over sildenafil.

Third, if the internal appeal is denied, Idaho law entitles you to an independent external review by a third-party organization within 45 days [7]. External review decisions are binding on Blue Cross of Idaho. A 2022 report from the Idaho Department of Insurance found that 47% of external reviews for prescription drug denials were overturned in the member's favor [16].

Tadalafil for BPH: A Separate Coverage Pathway

Tadalafil 5 mg daily received FDA approval for the treatment of signs and symptoms of BPH in October 2011, making it the only PDE5 inhibitor with this dual indication [9]. For men with both lower urinary tract symptoms (LUTS) due to BPH and erectile dysfunction, daily tadalafil treats both conditions with a single medication. This can simplify a regimen that might otherwise require an alpha-blocker (tamsulosin, alfuzosin) plus a separate ED drug.

The key trials for tadalafil in BPH demonstrated statistically significant improvements in International Prostate Symptom Score (IPSS). In a 12-week, placebo-controlled trial (N=1,058), tadalafil 5 mg daily improved total IPSS by -4.9 points versus -2.3 for placebo, a difference of -2.6 points (P<0.001) [17]. This improvement is comparable to the 2 to 3 point IPSS reduction seen with tamsulosin 0.4 mg in head-to-head comparisons.

Blue Cross of Idaho plans often cover daily tadalafil 5 mg under the BPH indication with fewer restrictions than for ED, because BPH is classified as a standard medical condition rather than a lifestyle concern. Your physician should use ICD-10 code N40.1 (benign prostatic hyperplasia with lower urinary tract symptoms) on both the prescription and any PA request. This coding distinction can make the difference between approval and denial.

Pharmacy Network and Mail-Order Options

Blue Cross of Idaho contracts with a broad retail pharmacy network across the state, including Albertsons, Walgreens, Rite Aid, Costco, and independent pharmacies. Copays are standard across in-network retail locations for a given plan, but pricing can vary slightly at out-of-network pharmacies where you would pay the full retail price and seek partial reimbursement.

Mail-order pharmacy is often the cheapest route for daily tadalafil. Blue Cross of Idaho's preferred mail-order vendor typically offers a 90-day supply for two copays instead of three, effectively giving you a 33% discount on cost-sharing. For a member with a $30 retail copay, a 90-day mail-order fill might cost $60 rather than $90. Some plans extend even deeper discounts for maintenance medications ordered through mail.

Specialty pharmacies generally do not handle tadalafil because it is not classified as a specialty drug. However, if your plan routes through a pharmacy benefit manager (PBM) like CVS Caremark, Express Scripts, or Optum Rx, the PBM's mail-order arm will be your default mail-order option. Blue Cross of Idaho uses multiple PBMs across its product lines, so your plan documents or member portal will identify which one manages your prescription benefit [2].

Comparing PDE5 Inhibitors Covered by Blue Cross of Idaho

Blue Cross of Idaho formularies typically include generic versions of four PDE5 inhibitors, each with distinct pharmacokinetics. Generic sildenafil (Viagra) has a 4 to 5 hour duration and is almost universally Tier 1 or Tier 2, making it the lowest-cost option. Generic tadalafil (Cialis) lasts up to 36 hours and is the only PDE5 inhibitor approved for daily dosing. Generic vardenafil (Levitra) has a 4 to 5 hour window similar to sildenafil. Avanafil (Stendra) has the fastest onset at approximately 15 minutes but remains brand-only and sits on a higher formulary tier [18].

The European Association of Urology (EAU) guidelines note: "All PDE5 inhibitors have similar efficacy rates of approximately 65-70% in the general ED population, but patient satisfaction varies based on onset time, duration of action, food interactions, and side-effect profile" [19]. Tadalafil's long half-life (17.5 hours) means it does not require meal-timing adjustments, unlike sildenafil, which should be taken on an empty stomach for optimal absorption. This pharmacokinetic advantage contributes to higher patient satisfaction scores. In a crossover preference study published in European Urology, 73% of men preferred tadalafil over sildenafil when both were offered sequentially, citing spontaneity and reduced performance anxiety as primary reasons [20].

For men whose primary goal is cost minimization, generic sildenafil remains the most affordable choice on virtually every Blue Cross of Idaho plan. For men who value flexibility in timing, treat concurrent BPH symptoms, or experienced side effects with sildenafil, generic tadalafil is the clinically supported alternative, and the insurance coverage pathway exists through PA and appeal mechanisms described above.